Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Cold & Flu Guard** is an over-the-counter oral and nasal spray product developed by Oral Science International for prevention and symptomatic relief of upper respiratory tract infections, including the common cold and influenza. It contains **Flavobac**, a patented citrus-derived bioflavonoid complex, together with **high molecular weight hyaluronic acid**, and is intended to act primarily by **forming a protective physical barrier** over the mucosa of the mouth, throat, and nose, thereby reducing pathogen contact with epithelial surfaces and helping shorten duration and severity of symptoms. It has been described as a natural health product or supplement rather than a prescription pharmaceutical, and its antiviral claims are based on barrier and surface-protective activity rather than a defined receptor-targeted pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cold & Flu Guard.